vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and INTEST CORP (INTT). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $32.8M, roughly 1.2× INTEST CORP). CODEXIS, INC. runs the higher net margin — 24.7% vs 3.8%, a 20.9% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -10.3%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $-1.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 4.9%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

INTTEST Corp designs, manufactures and distributes precision test and process control solutions for the global semiconductor manufacturing ecosystem. Its offerings include thermal management systems, test interface hardware, and wafer handling tools, serving semiconductor fabs, chip design firms, and automotive and industrial electronics end segments.

CDXS vs INTT — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.2× larger
CDXS
$38.9M
$32.8M
INTT
Growing faster (revenue YoY)
CDXS
CDXS
+91.7% gap
CDXS
81.3%
-10.3%
INTT
Higher net margin
CDXS
CDXS
20.9% more per $
CDXS
24.7%
3.8%
INTT
More free cash flow
CDXS
CDXS
$21.1M more FCF
CDXS
$19.6M
$-1.6M
INTT
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
4.9%
INTT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
INTT
INTT
Revenue
$38.9M
$32.8M
Net Profit
$9.6M
$1.2M
Gross Margin
94.8%
45.4%
Operating Margin
27.1%
3.9%
Net Margin
24.7%
3.8%
Revenue YoY
81.3%
-10.3%
Net Profit YoY
192.5%
-17.4%
EPS (diluted)
$0.13
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
INTT
INTT
Q4 25
$38.9M
$32.8M
Q3 25
$8.6M
$26.2M
Q2 25
$15.3M
$28.1M
Q1 25
$7.5M
$26.6M
Q4 24
$21.5M
$36.6M
Q3 24
$12.8M
$30.3M
Q2 24
$8.0M
$34.0M
Q1 24
$17.1M
$29.8M
Net Profit
CDXS
CDXS
INTT
INTT
Q4 25
$9.6M
$1.2M
Q3 25
$-19.6M
$-938.0K
Q2 25
$-13.3M
$-503.0K
Q1 25
$-20.7M
$-2.3M
Q4 24
$-10.4M
$1.5M
Q3 24
$-20.6M
$495.0K
Q2 24
$-22.8M
$230.0K
Q1 24
$-11.5M
$662.0K
Gross Margin
CDXS
CDXS
INTT
INTT
Q4 25
94.8%
45.4%
Q3 25
71.3%
41.9%
Q2 25
86.3%
42.6%
Q1 25
63.8%
41.5%
Q4 24
83.0%
39.7%
Q3 24
66.4%
46.3%
Q2 24
56.6%
40.6%
Q1 24
71.6%
43.8%
Operating Margin
CDXS
CDXS
INTT
INTT
Q4 25
27.1%
3.9%
Q3 25
-220.3%
-4.5%
Q2 25
-83.9%
-3.3%
Q1 25
-271.6%
-10.8%
Q4 24
-34.2%
5.7%
Q3 24
-129.0%
1.6%
Q2 24
-284.9%
1.0%
Q1 24
-69.6%
1.6%
Net Margin
CDXS
CDXS
INTT
INTT
Q4 25
24.7%
3.8%
Q3 25
-228.1%
-3.6%
Q2 25
-86.6%
-1.8%
Q1 25
-274.3%
-8.7%
Q4 24
-48.4%
4.1%
Q3 24
-160.8%
1.6%
Q2 24
-285.2%
0.7%
Q1 24
-67.4%
2.2%
EPS (diluted)
CDXS
CDXS
INTT
INTT
Q4 25
$0.13
$0.10
Q3 25
$-0.22
$-0.08
Q2 25
$-0.16
$-0.04
Q1 25
$-0.25
$-0.19
Q4 24
$-0.12
$0.13
Q3 24
$-0.29
$0.04
Q2 24
$-0.32
$0.02
Q1 24
$-0.16
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
INTT
INTT
Cash + ST InvestmentsLiquidity on hand
$78.2M
$14.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$103.6M
Total Assets
$147.8M
$151.3M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
INTT
INTT
Q4 25
$78.2M
$14.2M
Q3 25
$58.7M
$16.2M
Q2 25
$66.3M
$19.2M
Q1 25
$59.8M
$22.0M
Q4 24
$73.5M
$19.8M
Q3 24
$90.3M
$18.0M
Q2 24
$73.2M
$20.4M
Q1 24
$85.5M
$27.3M
Total Debt
CDXS
CDXS
INTT
INTT
Q4 25
$40.1M
Q3 25
$39.7M
$4.9M
Q2 25
$39.4M
$5.9M
Q1 25
$29.2M
$6.9M
Q4 24
$28.9M
$7.9M
Q3 24
$28.6M
$9.0M
Q2 24
$28.4M
$10.0M
Q1 24
$28.1M
$11.0M
Stockholders' Equity
CDXS
CDXS
INTT
INTT
Q4 25
$50.5M
$103.6M
Q3 25
$38.5M
$101.9M
Q2 25
$55.6M
$102.6M
Q1 25
$49.6M
$99.4M
Q4 24
$66.9M
$99.8M
Q3 24
$73.4M
$100.4M
Q2 24
$61.4M
$99.5M
Q1 24
$79.3M
$99.3M
Total Assets
CDXS
CDXS
INTT
INTT
Q4 25
$147.8M
$151.3M
Q3 25
$124.0M
$148.3M
Q2 25
$138.2M
$149.7M
Q1 25
$128.9M
$148.0M
Q4 24
$149.0M
$152.3M
Q3 24
$148.2M
$158.4M
Q2 24
$132.0M
$160.6M
Q1 24
$149.6M
$159.5M
Debt / Equity
CDXS
CDXS
INTT
INTT
Q4 25
0.79×
Q3 25
1.03×
0.05×
Q2 25
0.71×
0.06×
Q1 25
0.59×
0.07×
Q4 24
0.43×
0.08×
Q3 24
0.39×
0.09×
Q2 24
0.46×
0.10×
Q1 24
0.35×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
INTT
INTT
Operating Cash FlowLast quarter
$20.1M
$-1.0M
Free Cash FlowOCF − Capex
$19.6M
$-1.6M
FCF MarginFCF / Revenue
50.3%
-4.7%
Capex IntensityCapex / Revenue
1.3%
1.6%
Cash ConversionOCF / Net Profit
2.09×
-0.82×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
INTT
INTT
Q4 25
$20.1M
$-1.0M
Q3 25
$-7.7M
$3.5M
Q2 25
$-18.0M
$-688.0K
Q1 25
$-13.8M
$5.5M
Q4 24
$-16.5M
$2.6M
Q3 24
$-13.0M
$4.2M
Q2 24
$-12.2M
$-5.1M
Q1 24
$-7.8M
$2.1M
Free Cash Flow
CDXS
CDXS
INTT
INTT
Q4 25
$19.6M
$-1.6M
Q3 25
$-7.9M
$3.1M
Q2 25
$-20.5M
$-1.1M
Q1 25
$-15.1M
$5.3M
Q4 24
$-18.2M
$2.4M
Q3 24
$-14.0M
$3.7M
Q2 24
$-12.6M
$-5.4M
Q1 24
$-8.9M
$1.7M
FCF Margin
CDXS
CDXS
INTT
INTT
Q4 25
50.3%
-4.7%
Q3 25
-91.7%
11.8%
Q2 25
-133.6%
-4.1%
Q1 25
-199.6%
19.9%
Q4 24
-85.0%
6.6%
Q3 24
-109.0%
12.4%
Q2 24
-157.5%
-15.9%
Q1 24
-52.2%
5.8%
Capex Intensity
CDXS
CDXS
INTT
INTT
Q4 25
1.3%
1.6%
Q3 25
2.1%
1.6%
Q2 25
16.4%
1.6%
Q1 25
16.7%
0.9%
Q4 24
8.3%
0.4%
Q3 24
7.8%
1.7%
Q2 24
5.0%
0.9%
Q1 24
6.6%
1.1%
Cash Conversion
CDXS
CDXS
INTT
INTT
Q4 25
2.09×
-0.82×
Q3 25
Q2 25
Q1 25
Q4 24
1.72×
Q3 24
8.58×
Q2 24
-22.13×
Q1 24
3.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDXS
CDXS

Segment breakdown not available.

INTT
INTT

Environmental Technologies$8.3M25%
Semiconductor Market$6.9M21%
Thermal Testing Products$6.4M19%
Service And Other Products$4.8M15%
Oem Integrators And Distributor$3.5M11%
Semiconductor Production Test Products$3.0M9%

Related Comparisons